Internal Medicine, Pulmonary Disease · Tulsa, OK
NPI
1366564304
Since 2007
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
6
Medicare group memberships
Hospitals
9
Hospital affiliations
1245 S Utica Ave, Ste 330
Tulsa, OK, 74104
Phone (918) 382-6540
Groups this clinician bills Medicare through
Medicare paid, 2024
$876K
11,457 services
Medicare patients, 2024
1,574
Average age 74
Drug cost, 2024
$2.5M
5,059 prescriptions
Company payments, 2025
$13K
From 28 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hassan A Abouhouli was code 99233 (hospital e&m - subsequent), 4,730 times for 613 patients. In total Hassan A Abouhouli billed 11,457 services in 51 codes, and Medicare paid $876K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-05-01.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 4,730 | 613 | $87.52 | $414K |
| 99232 Hospital E&M - Subsequent | Facility | 3,514 | 576 | $58.22 | $205K |
| 99214 Office E&M - Established | Office | 700 | 502 | $91.02 | $64K |
| 99223 Hospital E&M - Initial | Facility | 635 | 577 | $126.74 | $80K |
| 94060 Pulmonary Function Testing | Facility | 244 | 230 | $7.24 | $1,766 |
| 94729 Pulmonary Function Testing | Facility | 244 | 230 | $6.27 | $1,529 |
| 99204 Office E&M - New | Office | 173 | 172 | $113.30 | $20K |
| 99213 Office E&M - Established | Office | 146 | 124 | $60.06 | $8,768 |
| 99291 Critical Care E&M | Facility | 124 | 68 | $154.48 | $19K |
| 99215 Office E&M - Established | Office | 108 | 75 | $130.18 | $14K |
| 94060 Pulmonary Function Testing | Office | 71 | 68 | $26.06 | $1,850 |
| 94729 Pulmonary Function Testing | Office | 71 | 68 | $37.84 | $2,687 |
| 94727 Pulmonary Function Testing | Office | 71 | 68 | $29.85 | $2,120 |
| 99239 Hospital Discharge Management | Facility | 67 | 67 | $84.64 | $5,671 |
| 31624 Bronchoscopy | Facility | 64 | 59 | $47.36 | $3,031 |
By year: 2022 $1.7M for 21,910 services; 2023 $1.4M for 17,834 services; 2024 $876K for 11,457 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hassan A Abouhouli prescribed most often to Medicare patients was Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter), with 833 prescriptions and refills. In total Hassan A Abouhouli wrote 5,059 Medicare prescriptions that cost $2.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 833 | 986 | 183 | $626K |
| Albuterol Sulfate Hfa Albuterol Sulfate | 539 | 617 | 232 | $13K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 499 | 573 | 119 | $358K |
| Azithromycin Generic | 355 | 389 | 210 | $2,457 |
| Theophylline Er Theophylline Anhydrous | 293 | 423 | 57 | $18K |
| Roflumilast Generic | 275 | 355 | 49 | $21K |
| Breo Ellipta Fluticasone/Vilanterol | 275 | 309 | 65 | $120K |
| Methylprednisolone Generic | 240 | 240 | 187 | $2,081 |
| Spiriva Respimat Tiotropium Bromide | 208 | 242 | 52 | $124K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 142 | 154 | 32 | $74K |
| Prednisone Generic | 135 | 143 | 43 | $528 |
| Levofloxacin Generic | 128 | 128 | 110 | $830 |
| Symbicort Budesonide/Formoterol Fumarate | 96 | 120 | 37 | $28K |
| Anoro Ellipta Umeclidinium Brm/Vilanterol Tr | 90 | 132 | 18 | $59K |
| Ventolin Hfa Albuterol Sulfate | 86 | 97 | 29 | $5,415 |
Brand drugs: 2,820 claims; generic drugs: 2,239 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hassan A Abouhouli $13K ($13K in general payments such as food, travel and fees) from 28 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $11K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 33 | $11K |
| GlaxoSmithKline, LLC. GSK | 29 | $482 |
| Regeneron Healthcare Solutions, Inc. REGN | 19 | $273 |
| Pulmonx Corporation LUNG | 6 | $229 |
| Genzyme Corporation SNY | 9 | $142 |
| BSN Medical Inc | 1 | $107 |
| Viatris Specialty LLC | 5 | $97.12 |
| Mallinckrodt Hospital Products Inc. | 3 | $89.47 |
| Amgen Inc. AMGN | 4 | $68.69 |
| Insmed, Inc. INSM | 4 | $65.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.